Engineered Exosomes with Growth Differentiation Factor-15 Overexpression Enhance Cardiac Repair After Myocardial Injury
Ailin Zou,Tingting Xiao,Boyu Chi,Yu Wang,Lipeng Mao,Dabei Cai,Qingqing Gu,Qianwen Chen,Qingjie Wang,Yuan Ji,Ling Sun
DOI: https://doi.org/10.2147/ijn.s454277
IF: 7.033
2024-04-06
International Journal of Nanomedicine
Abstract:Ailin Zou, 1, &ast Tingting Xiao, 1, &ast Boyu Chi, 1, 2 Yu Wang, 1 Lipeng Mao, 1, 2 Dabei Cai, 1, 2 Qingqing Gu, 1 Qianwen Chen, 1 Qingjie Wang, 1 Yuan Ji, 1 Ling Sun 1, 2 1 Department of Cardiology, the Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China; 2 Changzhou Clinical Medical College, Dalian Medical University, Dalian, Liaoning, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ling Sun; Qingjie Wang, Department of Cardiology, the Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu, 213003, People's Republic of China, Email ; Background: Cardiac repair remains a thorny issue for survivors of acute myocardial infarction (AMI), due to the regenerative inertia of myocardial cells. Cell-free therapies, such as exosome transplantation, have become a potential strategy for myocardial injury. The aim of this study was to investigate the role of engineered exosomes in overexpressing Growth Differentiation Factor-15 (GDF-15) (GDF15-EVs) after myocardial injury, and their molecular mechanisms in cardiac repair. Methods: H9C2 cells were transfected with GDF-15 lentivirus or negative control. The exosomes secreted from H9C2 cells were collected and identified. The cellular apoptosis and autophagy of H 2 O 2 -injured H9C2 cells were assessed by Western blotting, TUNEL assay, electron microscopy, CCK-8 and caspase 3/7 assay. A rat model of AMI was constructed by ligating the left anterior descending artery. The anti-apoptotic, pro-angiogenic effects of GDF15-EVs treatment, as well as ensuing functional and histological recovery were evaluated. Then, mRNA sequencing was performed to identify the differentially expressed mRNAs after GDF15-EVs treatment. Results: GDF15-EVs inhibited apoptosis and promoted autophagy in H 2 O 2 injured H9C2 cells. GDF15-EVs effectively decreased the infarct area and enhanced the cardiac function in rats with AMI. Moreover, GDF15-EVs hindered inflammatory cell infiltration, inhibited cell apoptosis, and promoted cardiac angiogenesis in rats with AMI. RNA sequence showed that telomerase reverse transcriptase (TERT) mRNA was upregulated in GDF15-EVs-treated H9C2 cells. AMPK signaling was activated after GDF15-EVs. Silencing TERT impaired the protective effects of GDF15-EVs on H 2 O 2 -injured H9C2 cells. Conclusion: GDF15-EVs could fulfil their protective effects against myocardial injury by upregulating the expression of TERT and activating the AMPK signaling pathway. GDF15-EVs might be exploited to design new therapies for AMI. Keywords: exosomes, growth differentiation factor-15, telomerase reverse transcriptase, acute myocardial infarction Acute myocardial infarction (AMI) remains a culprit of death worldwide. Early prevention, effective intervention and appropriate care have reduced the mortality of AMI, but survivors may still face the risk of lethal complications, due to post-infarction scar formation, pathological remodeling, and ventricular arrhythmias. 1,2 Therefore, post-infarction myocardial repair has slipped into the research hotspot, especially that about cell therapy. 3 For example, cardiomyocyte and stem cell transplantation have been advocated, but transplanted cells manifest a poor survival and a low plasticity, both of which lead to unsatisfactory outcomes. 4,5 In contrast, recent research advances have demonstrated that paracrine bioactive molecules from cardiomyocytes can activate endogenous tissue repair and regeneration. 6,7 Collective evidence supports that cardiomyocyte-derived exosome transplantation can improve cardiac function after MI, with advantages of easy exosome isolation and expansion, mild immune rejection, and a high success rate. 8,9 In this cell-free therapeutic strategy, bioactive molecules are transferred directly into injured recipient cells to reduce pathological inflammation, inhibit cardiomyocyte apoptosis, necrosis and remodeling, as well as promote neovascularization. 3,10 Autocrine and paracrine communication between cells regulates tissue or organismal function. To provide specific signaling and targeted delivery, cells secrete membrane vesicles and distribute them into the peripheral blood, urine, saliva and other body fluids. Extracellular vesicles can be categorized based on diameter size, as mentioned in MISEV guidelines (2018). Usually, EVs < 100 nm or <200 nm in -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology